Mungmunpuntipantip, Rujittika1,; Wiwanitkit, Viroj2,3,4
1Private Academic Consultant, Bangkok, Thailand
2Department of Biological Science, Joseph Ayobaalola University, Ikeji-Arakeji, Nigeria
3Department of Community Medicine, Dr DY Patil University, Pune, Maharashtra, India
4Faculty of Medicine, University of Nis, Nis, Serbia
Address for correspondence: Dr. Rujittika Mungmunpuntipantip, Private Academic Consultant, Bangkok, Thailand. E-mail: [email protected]
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Dear Editor
New zoonotic pox diseases have emerged, posing a global concern in addition to the well-known pox infections.[1] Owing to possible transmission from animal to human, an extremely rare variant of pox known as monkeypox has resurfaced and re-emerged.[1] After spreading over Europe and North America, monkeypox constituted a substantial threat to public health by 2022.[2] Monkeypox is an uncommon strain of the lesser-known pox that has resurfaced due to zoonosis. Human-to-human transmission is now being studied and there is a high probability.[1] As the number of cases reported in various countries rise in many countries around the world, the international medical community is concerned. Considering this, cautious planning to coincide with a potential monkeypox outbreak is important. It is critical to focus on acquiring new information regarding the ailment to ensure that the illness is eradicated. As a result of the latest outbreak, medical concerns have resurfaced. The clinical link between infection and transplant recipient is rarely recognized in transplantation medicine. To the best of our knowledge, only one instance of monkeypox in a lupus patient has been documented in the previous literature.[3] Among 34 instances, one male case with underlying lupus nephritis was published in 2015.[3] In this example, the clinical presentation is usual, with a fever and a skin rash, and the patient recovers entirely.[3] There are no signs that the situation is deteriorating. However, as previously said, the amount of information about lupus sufferers is relatively limited. Because a change in white blood immune cells, lymphocytes, and platelets is a common sign of monkeypox, it has the potential to exacerbate an abnormal scenario in a monkeypox patient who also has lupus. The connection between monkeypox and lupus is now being investigated.
Financial support and sponsorship
Not applicable.
Conflicts of interest
There are no conflicts of interest.
References
1. Wiwanitkit S, Wiwanitkit V. Atypical zoonotic pox: Acute merging illness that can be easily forgotten. J Acute Dis 2018;7:88-9
2. Mungmunpuntipantip V, Wiwanitkit VRe-emerging monkeypox: an old disease to be monitored. BMJ Rapid Response. Available from: https://www.bmj.com/content/377/bmj.o1239/rr-1. [Last accessed on 21 May 2022]
3. Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 2005;41:1742-51
